DHGWA
GSK icon

Dixon Hughes Goodman Wealth Advisors’s GSK GSK Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$90K Buy
1,657
+546
+49% +$29.7K 0.03% 256
2021
Q4 		$61K Buy
+1,111
New +$57.8K 0.02% 242

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's GSK Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors increased its GSK (GSK) stake by 49% in Q1 2022, buying an estimated $29.7K and bringing the position to 1,657 shares worth $90K. The position accounts for 0.03% of the portfolio, ranked #256.

Dixon Hughes Goodman Wealth Advisors first reported a position in GSK in Q4 2021 and has held it in 2 quarters since. 929 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

  • Dixon Hughes Goodman Wealth Advisors held 1,657 shares of GSK worth $90K as of Q1 2022.
  • Dixon Hughes Goodman Wealth Advisors bought 546 GSK shares in Q1 2022, an estimated $29.7K.
  • GSK made up 0.03% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #256 holding.
  • Dixon Hughes Goodman Wealth Advisors first reported a position in GSK in Q4 2021 and has held it in 2 quarters since.
  • 929 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.